According to government sources, while Pfizer had sought clinical
trial waiver for its vaccine, the SEC did not considered its proposal
and insisted on a bridging study that it opined should be conducted on
Indian population.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-withdraws-application-for-emergency-use-of-its-covid-vaccine-in-india/articleshow/80701405.cms
No comments:
Post a Comment